LSGRX
Price
$32.61
Change
-$0.34 (-1.03%)
Updated
Aug 29 closing price
Net Assets
17.67B
RGEBX
Price
$81.56
Change
-$0.76 (-0.92%)
Updated
Aug 29 closing price
Net Assets
327.53B
Interact to see
Advertisement

LSGRX vs RGEBX

Header iconLSGRX vs RGEBX Comparison
Open Charts LSGRX vs RGEBXBanner chart's image
Loomis Sayles Growth Y
Price$32.61
Change-$0.34 (-1.03%)
VolumeN/A
Net Assets17.67B
American Funds Growth Fund of Amer R2E
Price$81.56
Change-$0.76 (-0.92%)
VolumeN/A
Net Assets327.53B
LSGRX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
LSGRX vs. RGEBX commentary
Aug 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is LSGRX is a Buy and RGEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 328B vs. LSGRX (17.7B). LSGRX (0.00) and RGEBX (0.00) have matching dividends . LSGRX was incepted earlier than RGEBX: LSGRX (34 years) vs RGEBX (11 years). RGEBX (1.09) is less costly to investors than LSGRX (0.67). RGEBX is a more actively managed with annual turnover of: 25.00 vs. LSGRX (10.00). RGEBX has a lower initial minimum investment than LSGRX: RGEBX (250) vs LSGRX (100000). LSGRX annual gain was more profitable for investors over the last year : 21.32 vs. RGEBX (13.67). LSGRX return over 5 years is better than : 41.36 vs. RGEBX (33.24).
LSGRXRGEBXLSGRX / RGEBX
Total Expense Ratio0.661.0961%
Annual Report Gross Expense Ratio0.671.0961%
Fund Existence34 years11 years-
Gain YTD11.46814.16681%
Front LoadN/AN/A-
Min. Initial Investment10000025040,000%
Min. Initial Investment IRAN/AN/A-
Net Assets17.7B328B5%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.3213.67156%
Returns for 3 years66.5052.58126%
Returns for 5 years41.3633.24124%
Returns for 10 years219.5494.86231%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NBIX139.600.66
+0.48%
Neurocrine Biosciences
BWMX13.370.05
+0.38%
Betterware de Mexico SAPI de CV
TRN28.42-0.19
-0.66%
Trinity Industries
SLXN7.32-0.41
-5.37%
Silexion Therapeutics Corp
QUIK5.13-0.39
-7.07%
QuickLogic Corp